Blood Clot News and Research RSS Feed - Blood Clot News and Research

A Blood Clot is a mass of blood that forms when blood platelets, proteins, and cells stick together. When a blood clot is attached to the wall of a blood vessel, it is called a thrombus. When it moves through the bloodstream and blocks the flow of blood in another part of the body, it is called an embolus.
Male stroke patients who live alone are at greater risk of premature death

Male stroke patients who live alone are at greater risk of premature death

Men who live alone have a considerably greater long-term risk of dying prematurely than other patients. This is shown in a doctoral thesis that followed 1,090 stroke cases in western Sweden. [More]
Platelet transfusion treatment increases death in people with certain rare blood cell disorders

Platelet transfusion treatment increases death in people with certain rare blood cell disorders

People hospitalized with certain rare blood cell disorders frequently receive a treatment that is associated with a two- to fivefold increase in death, according to a new study that reviewed hospital records nationwide. The study authors recommend that for these rare disorders, doctors should administer the treatment, a platelet transfusion, only in exceptional circumstances. [More]
Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF). [More]
Treatment for stroke: Intra-arterial treatment more effective than standard medical care for clot removal

Treatment for stroke: Intra-arterial treatment more effective than standard medical care for clot removal

Study results released today in The New England Journal of Medicine gave the world of stroke care more evidence that physicians are winning the battle against this debilitating disease, which affects as many as one in six people. [More]
Riding roller coasters can trigger stroke in children

Riding roller coasters can trigger stroke in children

Riding a couple roller coasters at an amusement park appears to have triggered an unusual stroke in a 4-year-old boy, according to a report in the journal Pediatric Neurology. [More]
Studies presented at ASH meeting compare new, standard-of-care treatments for blood clots

Studies presented at ASH meeting compare new, standard-of-care treatments for blood clots

Studies presented at the 56th American Society of Hematology Annual Meeting and Exposition compare new and standard-of-care treatments for blood clots and further illuminate clot risks in vulnerable populations, such as cancer patients. [More]
Daiichi Sankyo releases new formulation of LIXIANA 60 mg Tablets

Daiichi Sankyo releases new formulation of LIXIANA 60 mg Tablets

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has launched a new formulation of LIXIANA 60 mg Tablets (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban, approval to market: September 26, 2014; NHI drug price listing: November 25, 2014) in Japan for the recently approved indications: the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and the treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary thromboembolism (PE)]. [More]
New study identifies crizotinib drug as possible new coating for drug-eluting stents

New study identifies crizotinib drug as possible new coating for drug-eluting stents

A new study has identified an FDA approved cancer drug, crizotinib, as a possible new coating for drug-eluting stents. Researchers found that crizotinib in mice helped prevent the narrowing of blood vessels after stenting without affecting the blood vessel lining. [More]
UCSD engineers propose new single-ventricle heart surgery for children

UCSD engineers propose new single-ventricle heart surgery for children

Engineers at the University of California, San Diego, are proposing a new surgical intervention for children born with a single ventricle in their heart--instead of the usual two. The new approach would potentially reduce the number of surgeries the patients have to undergo in the first six months of life from two to just one. If successful, it would also create a more stable circuit for blood to flow from the heart to the lungs and the rest of the body within the first days and months of life. [More]
Monash University research explores long-term costs for two main causes of stroke

Monash University research explores long-term costs for two main causes of stroke

New data shows that healthcare and personal costs to support survivors of stroke remains high 10 years on. [More]
Loyola neurologist lists seven surprising things about strokes

Loyola neurologist lists seven surprising things about strokes

In recognition of World Stroke Day Oct. 29, Loyola University Medical Center neurologist Jose Biller, MD, lists seven surprising things you may not know about strokes. [More]
Researchers discover mechanism that leads to generation of new nerve cells after stroke

Researchers discover mechanism that leads to generation of new nerve cells after stroke

A previously unknown mechanism through which the brain produces new nerve cells after a stroke has been discovered at Lund University and Karolinska Institutet in Sweden. The findings have been published in the journal SCIENCE. [More]
GWU researcher receives AHA grant to study diffuse brain swelling, injury in ICH patients

GWU researcher receives AHA grant to study diffuse brain swelling, injury in ICH patients

Shahram Majidi, M.D., a second-year resident in the Department of Neurology at the George Washington University School of Medicine and Health Sciences, received at $154K grant from the American Heart Association to study the presence of diffuse brain swelling and injury in patients with intracerebral hemorrhage (ICH). [More]
New guidance can help physicians determine best oral blood thinners for patients

New guidance can help physicians determine best oral blood thinners for patients

Physicians around the world now have guidance that can help them determine the best oral blood thinners to use for their patients suffering from blood clots in their veins, thanks to a patient of The Ottawa Hospital who asked his physician a question he couldn't answer. [More]
Thrombus aspiration for acute myocardial infarction does not reduce mortality

Thrombus aspiration for acute myocardial infarction does not reduce mortality

Thrombus aspiration for acute myocardial infarction (AMI) does not reduce mortality or other clinical endpoints long term, according to the awaited one-year follow-up results from the Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE) trial. [More]
Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO (rivaroxaban) to include additional high-risk patient populations. [More]
ProMedica participates in innovative research into development of non-invasive treatment for BPH

ProMedica participates in innovative research into development of non-invasive treatment for BPH

ProMedica is participating in innovative research into the development of a safe, non-invasive treatment for BPH or enlarged prostate. BPH can block the flow of urine out of the bladder and cause bladder, urinary tract or kidney problems. [More]
Study explores the effectiveness of stents in treating vein obstructions

Study explores the effectiveness of stents in treating vein obstructions

Jobst Vascular Institute is conducting pioneering research that looks at using stents to treat blocked veins. For years, stents - small mesh tubes - have been used to treat narrowed or blocked arteries; however none are specifically designed for use in veins. [More]
First Edition: August 19, 2014

First Edition: August 19, 2014

Today's early morning highlights from the major news organizations, including stories about a how a hospital system's data was hacked, involving as many as 4.5 million patients' records. [More]
Delay in correcting abnormal cardiac rhythm linked with greater risk of thromboembolic complications

Delay in correcting abnormal cardiac rhythm linked with greater risk of thromboembolic complications

A delay of 12 hours or longer to correct an abnormal cardiac rhythm from atrial fibrillation was associated with a greater risk of thromboembolic complications such as stroke, according to a study in the August 13 issue of JAMA. [More]